Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum InMed Pharmaceuticals Inc INM

InMed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. The Company is engaged in developing a pipeline of prescription-based products, including rare cannabinoids and cannabinoid analogs, targeting the treatment of diseases with high unmet medical needs, as well as developing proprietary manufacturing technologies to produce rare cannabinoids for sale in the health and wellness... see more

NDAQ:INM - Post Discussion

View:
Post by Linc1581 on Jul 07, 2020 4:12pm

Brutal

down 25% since the reverse split, I like how they say it won't affect the sp in that it is 1:1 in terms of value pre and post but fail to foresee the 20% drop from the selling. There is a high chance they will miss listing on NASDAQ and dilute again. Very disappointing with the miss on warrants and continued downward spiral and no real news. NASDAQ will be more of the same if they were able to get listed
Comment by Bullknit101 on Jul 07, 2020 5:14pm
My guess is that they already planned for the risk of an SP drop hence why they opted for 33 RS. We should have an idea soon as to when they might list on NASDAQ. Not sure what folks are saying no news. They are hitting their milestones but yeah, we would a license deal sooner than later.
Comment by Linc1581 on Jul 07, 2020 5:21pm
my concern is the continued drop and not making the listing requirement. Also without news and uplisting would be the same as when they uplisted to tsx where it went from 1.47 to .265 cad for the reverse. The only plus so far is that volume has been up compared to before but it's been all selling
Comment by Linc1581 on Jul 07, 2020 7:01pm
currently at 4.85 us and the requirement is 4us. They have atleast 6-8 weeks before listing...don't think they will stay above 4 US in the time frame
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities